id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-D-1825-0018,FDA,FDA-2020-D-1825,Guidance Documents Related to Coronavirus Disease 2019; Availability,Notice,Notice of Availability,2022-03-04T05:00:00Z,2022,3,2022-03-04T05:00:00Z,,2022-03-04T15:55:01Z,2022-04637,0,0,0900006484fb9ebf
FDA-2020-D-1825-0017,FDA,FDA-2020-D-1825,Investigational COVID-19 Convalescent Plasma; Guidance for Industry,Other,Guidance,2022-01-10T05:00:00Z,2022,1,2022-01-10T05:00:00Z,,2022-01-10T14:52:32Z,,0,0,0900006484f1672e